Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA's internal review of Acadia's Parkinson's drug raises safety, benefit concerns
FDA's internal review of Acadia's Parkinson's drug raises safety, benefit concerns
FDA's internal review of Acadia's Parkinson's drug raises safety, benefit concerns
Submitted by
admin
on March 26, 2016 - 12:41pm
Source:
Fierce Biotech
News Tags:
FDA
Acadia
Parkinson's Disease Psychosis
Nuplazid
Headline:
FDA's internal review of Acadia's Parkinson's drug raises safety, benefit concerns
Do Not Allow Advertisers to Use My Personal information
